
(Pronouns He/Him). DAD/Husband/Scientist @ProstateCancer @CancerGenomics @Biomarker_Research @Mountain_Lover @DNA repair @Signature 'tweet are mine'
Seattle, WA
Joined May 2009
- Tweets768
- Following698
- Followers393
- Likes1.7K
Pinned Tweet
Excited to release my lab's first preprint! A foundational model for clone & epistasis-aware biomarkers. This approach addresses key challenges in understanding genetic interactions & clonal dynamics.
Looking forward to feedback & new collaborations! biorxiv.org/content/10.1101/…
So glad to be a part in this photo. Great updates. – at Wauwatosa, WI
The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most.
For 33 years, PCF has brought science and lived experience together to move research forward.
#PCFRetreat26
Navonil DS retweeted
The world’s leading prostate cancer researchers came to Carlsbad to share their work, and patients and caregivers came with the questions that matter most.
For 33 years, PCF has brought science and lived experience together to move research forward.
#PCFRetreat26
Navonil DS retweeted
Delighted that he is joining precision/rare/phase 1
Happy to Join MCW Cancer Center as Assistant Professor and Medical Oncologist - Yu Fujiwara
@waraonc23jp
oncodaily.com/career/yu-fuji…
Navonil DS retweeted
I’m excited to launch Science in GU Oncology, a new monthly newsletter in partnership with @urotoday Each issue will cover the latest scientific advances in GU cancers and what they mean for patient care. bit.ly/4bMIfPn
Navonil DS retweeted
One diagnosis sparked a movement. 💙
After being diagnosed with advanced prostate cancer, Michael Milken founded the Prostate Cancer Foundation. His mission: accelerate research and improve outcomes for patients everywhere. More than 30 years later, that mission remains true.
Navonil DS retweeted
Finally !! a CAR-T that works on solid tumors.
Nature paper… 32 out of 36 patients had regression of advanced #cancer.
Target rglypican and tgf beta.
@IntegrativeCCA $IBRX #anktiva will enhance
nature.com/articles/s41586-0…
Navonil DS retweeted
The Center for Precision Oncology and Rare Cancers/Precision Medicine and Rare Cancer Clinic at MCW could not function without our pharmacists
pubmed.ncbi.nlm.nih.gov/4245…
Navonil DS retweeted
Now online: Arachidonic Acid Metabolism in PMN-MDSCs Suppresses Antitumor Capacity of T Cells in KRAS -Mutant Cholangiocarcinoma doi.org/10.1158/2159-8290.CD…
Navonil DS retweeted
Now online: Germline CDK12 variants in aggressive prostate cancer doi.org/10.1158/2159-8290.CD…
Navonil DS retweeted
FDA approves Orca Bio’s T cell therapy for blood cancer patients statnews.com/2026/07/01/fda-… via @statnews
Navonil DS retweeted
Hope changes everything.
At its heart, the Michels’ $27 million gift to MCW’s Center for Cancer Discovery is about the families facing a cancer diagnosis today—and those who will face one tomorrow. By investing in groundbreaking research, Tim and Barbara Michels are helping bring new hope, new possibilities, and new pathways to better outcomes for patients everywhere.
Obituary: J Craig Venter (1946-2026) maverick biotechnologist who sequenced the human genome
go.nature.com/4dussWD
Navonil DS retweeted
Online here: nature.com/articles/s41586-0…
Open access here: rdcu.be/ff6YJ
Key supporters of this work are @CR_UK , @CRUKLungCentre , @UCLHresearch alongside many others
Navonil DS retweeted
As we close out #WomensHistoryMonth, we honor the women of PCF whose leadership is helping shape the future of prostate cancer. Their voices, and women’s voices everywhere, spark conversations that lead to early detection and save lives. 💙
Navonil DS retweeted
If you or a loved one has prostate cancer, germline genetic and somatic testing can open doors—to better treatment options, clinical trials, and a clearer picture of your family's cancer risk.
Medical oncologist Dr. @EHeath4100 walks you through: bit.ly/47wv4Qt
#MedEd
Navonil DS retweeted
FUO 2026 applications are open! Senior urology residents (PGY3 in Aug 2026) are invited to join the inaugural SUO Future Urologic Oncologists program in Indianapolis (July 24–26) for mentorship, education, and networking with leaders in urologic oncology. Apply by April 20!
Navonil DS retweeted
Prostate Cancer Working Group 4: What Does Its Work Mean for the Busy Clinician? dailynews.ascopubs.org/do/pr…
Stay tuned this Thursday at #GU26 and @JCO_ASCO! @DukeGUCancer @DukeCancer @ThePCCTC
Navonil DS retweeted
Join us in ending the stigma of getting tested for prostate cancer – early detection can save lives. Get a simple PSA blood test. Check the Box!
Basketball Hall of Fame checks in to Prostate Cancer Foundation effort to save lives mmm-online.com/news/basketba… @PCFnews
Navonil DS retweeted
Thrilled to share the latest from @gungulati and team in collab with #MattFreedman. #LiquidBiopsy can reveal gene expression in cancer by integrating circulating histone mods and cfDNA fragmentation patterns. Excited to see how this expands the reach of precision oncology!
We infer earthquakes from distant vibrations and stars from photons emitted light-years away.
Can we reconstruct a patient’s tumor biology from the signals it sheds into blood?
Introducing APEX (Associating Plasma Epigenomics with eXpression), our framework for inferring cancer expression from plasma.
Preprint: biorxiv.org/content/10.64898…
@biorxivpreprint @DanaFarber @DrChoueiri @SylvanBacaLab #FreedmanLab





























